Apocrine gland anal sac adenocarcinoma (AGASACA) most commonly presents with signs of mechanical obstruction from the primary tumor or enlarged regional lymph nodes, with paraneoplastic hypercalcemia — manifesting as polyuria and polydipsia — present in approximately 25% to 50% of cases. Journal of Vete… AGASACA comprises approximately 17% of perianal malignancies in dogs and 2% of all skin tumors, and it is one of the most common causes of paraneoplastic hypercalcemia in the species. Topics in Compa…+1 Metastasis to the iliosacral lymph nodes is detected before distant spread to lungs, liver, and spleen, and the metastatic rate reaches 50% to 90% by the time of diagnosis. Journal of Vete…+1
Staging requires 3-view thoracic radiographs, abdominal ultrasound with or without abdominal and thoracic CT, and ionized calcium measurement. AAHA Clinical G… CT is the gold standard for primary tumor size measurement and is more accurate than ultrasonography for identifying abnormal lymph nodes. Journal of the… Altered ultrasonographic appearance of lymph nodes is highly consistent with metastatic disease on cytology and histopathology. Journal of Smal…
Closed anal sacculectomy is the recommended surgical technique for AGASACA, as it keeps the anal sac intact, reducing contamination of surrounding tissue and the risk of postoperative infection; the open technique is considered inappropriate for neoplastic anal sacs. Journal of the… A modified closed technique facilitating full anal sac duct excision has been described and is well tolerated, with no intraoperative complications and only one minor postoperative complication (paraparesis, which resolved) reported. Journal of the… Perineal surgery carries a minor complication rate of approximately 12%, with an additional 12% of cases requiring further surgical intervention. Journal of Smal…
Lymphadenectomy for locoregional iliosacral lymph node metastasis is a recommended adjunct to primary tumor excision, with lymph node metastasectomy carrying low morbidity — minor controllable intraoperative bleeding was the only complication in 5% of metastasectomy procedures. Journal of Smal…+1 From the time of detection of disease recurrence, a second surgical intervention yields a median additional survival of 283 days. Journal of Smal… Preservation of fecal continence is a primary surgical goal; in dogs, up to 50% of the external anal sphincter can be removed without permanent fecal incontinence. Journal of the…
Primary tumor size and lymph node metastasis at diagnosis are the two factors that significantly impact outcome. Veterinary and… Dogs with advanced systemic metastasis generally have survival times under 1 year, while dogs undergoing surgical intervention can achieve survival times of 1.5 to over 3 years and cure. AAHA Clinical G… Primary tumor volume greater than 10 cm³ and systemic (non-nodal) metastasis are negative prognostic indicators. AAHA Clinical G… Median overall survival with surgery is 703 days, and median time to progression is 384 days. Veterinary and…
Adjuvant chemotherapy is commonly incorporated into multimodal treatment plans, though a definitive survival benefit has not been clearly established. Topics in Compa… Carboplatin-based and mitoxantrone-based chemotherapy are the primary systemic options; adjuvant carboplatin is well tolerated, but differences in overall survival and time to progression between dogs receiving adjuvant carboplatin and those that did not failed to reach statistical significance. Veterinary and…+1 Toceranib phosphate used postoperatively yields a median time to progression of 360 days versus 298 days for surgery alone. Journal of Vete…
For unresectable or advanced disease, hypofractionated radiation therapy (RT) achieves a partial response in 38% of dogs, with improvement or resolution of tumor-related clinical signs in 63%. Veterinary and… For dogs with hypercalcemia of malignancy, RT alone resolves hypercalcemia in 31%, with an additional 46% achieving resolution when RT is combined with prednisone and/or bisphosphonates. Veterinary and… Median overall survival with hypofractionated RT is 329 days, and median progression-free survival is 289 days; radiation toxicities are mild and infrequent. Veterinary and…
| Modality | Protocol | Efficacy | Key Caveat |
|---|---|---|---|
| Surgery alone | Closed anal sacculectomy ± lymphadenectomy | Median OS 703 days; median TTP 384 days Veterinary and… | Minor perineal complication rate ~12%; 12% require re-intervention Journal of Smal… |
| Adjuvant carboplatin | Carboplatin-based chemotherapy post-surgery | No statistically significant OS or TTP benefit vs. surgery alone Veterinary and… | Well tolerated; treatment of progressive disease prolongs survival Veterinary and… |
| Adjuvant toceranib phosphate | Toceranib phosphate post-surgery | Median TTP 360 days vs. 298 days surgery alone Journal of Vete… | Role in AGASACA specifically requires further definition Journal of Vete… |
| Hypofractionated RT (unresectable) | Hypofractionated RT ± prednisone/bisphosphonates | 38% partial response; median OS 329 days; median PFS 289 days Veterinary and… | Hypercalcemia resolution in 31% with RT alone, 77% with RT + prednisone/bisphosphonates Veterinary and… |
Would you like to go deeper on surgical technique selection — specifically the modified versus traditional closed approach and their comparative complication and recurrence rates?